Non Steroidal Anti Inflammatory Drug (NSAIDS) News and Research

RSS

Ibruprofen and other commonly used painkillers for treating inflammation may increase the risk of heart attack

Patients should not stop taking the drugs involved - non-steroidal anti-inflammatory drugs (NSAIDS) - but further investigation into these treatments is needed, say the authors.

10 Jun 2005

Survey highlights need for primary care guidance on NSAID use

New guidance on NSAID (non-steroidal anti-inflammatory drug) use is urgently needed to ensure the best patient care, European experts said today. The news coincides with the results from a European survey of 626 arthritis patients which found that many are confused and worried about the potential side-effects of their medication.

10 Jun 2005

Ibuprofen may cause heart attacks - full disclosure of all data - including industry safety data - is essential

Speaking at the annual European conference of rheumatology, EULAR 2005, in Vienna, Austria, today (Friday 10 June 2005), Dr. Gurkirpal Singh, from Stanford University, USA, said:

10 Jun 2005

Commonly used painkillers for treating inflammation may increase the risk of heart attack

Patients should not stop taking the drugs involved - non-steroidal anti-inflammatory drugs (NSAIDS) - but further investigation into these treatments is needed, say the authors.

9 Jun 2005

Study suggests continuous NSAID treatment more effectively reduces X-Ray progression than intermittent treatment

A widely under-recognized form of arthritis, ankylosing spondylitis (AS) is a chronic, progressive disease targeting the spine.

2 Jun 2005

Ibuprofen use is associated with an increased risk of breast cancer

Ibuprofen use is associated with an increased risk of breast cancer, and long-term daily use of aspirin is associated with an increased risk of estrogen receptor/progesterone receptor (ER/PR)-negative breast cancer, according to a new study in the June 1 issue of the Journal of the National Cancer Institute.

30 May 2005

Study shows how COX-2 inhibitors lead to heart disease

University of Pennsylvania School of Medicine researchers have found additional evidence that may help explain how selective inhibitors of COX-2 might predispose individuals to heart disease and stroke.

26 May 2005

Use of a common type of antidepressant may increase gastrointestinal (GI) bleeding

In fact, the study suggests that the increase is similar to that associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs, known as pain relievers). DDW is the largest international gathering of physicians, academics and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

17 May 2005

Research offers hope for treatment of age-related blindness

Rheumatoid arthritis patients treated with anti-inflammatory drugs are 10 times less likely to develop age-related macular degeneration (AMD), the most common form of blindness in people over 55, researchers at the University of British Columbia and University of Saskatchewan have found.

27 Apr 2005

Arthritis medications (methotrexate and leflunomide) commonly used in adults are safe and effective in children

An international team of researchers, led by Dr. Earl Silverman of The Hospital for Sick Children (Sick Kids), has found that two arthritis medications (methotrexate and leflunomide) commonly used in adults are safe and effective in children. This research is reported in the April 21, 2005 issue of The New England Journal of Medicine.

20 Apr 2005

NSAIDs okay for tonsillectomy, new study finds

When children have their tonsils removed, nonsteroidal anti-inflammatory drugs can be used for pain relief with no significant increase in bleeding and with less nausea and vomiting, according to a systematic review of current evidence.

19 Apr 2005

Pfizer separately agrees to suspend sales of Bextra due to FDA evaluation of risks of rare but serious skin reactions

Pfizer said today it will work with the U.S. Food and Drug Administration (FDA) to add expanded risk information in the Celebrex label following an FDA decision announced this morning to require boxed warnings of potential cardiovascular risk for all COX-2 pain relievers and all NSAIDs, including older non-specific drugs such as ibuprofen and naproxen.

7 Apr 2005

Animi-3 may offer hope for rheumatoid arthritis

Animi-3, a prescription medication from PBM Pharmaceuticals, Inc., contains ingredients that may have a beneficial, protective effect in inflammatory diseases such as rheumatoid arthritis (RA).

7 Apr 2005

Pfizer withdraws Bextra from market

Despite an expert panel stating last month that the three COX-2 drugs Vioxx, Bextra and Celebrex were safe enough to be marketed, the U.S. Food and Drug Administration (FDA) has this week told drug manufacturer Pfizer to remove the drug Bextra from the market and a statement by Pfizer confirms that the European Union regulators have done the same.

7 Apr 2005

Experts call for improved access to treatment for psoriatic arthritis

MPs gathered at the House of Commons on Tuesday (April 5th) as experts and patient groups urged members of parliament to lobby for improved access to treatment for patients with psoriatic arthritis, a little known and poorly understood condition in which patients experience symptoms of both psoriasis and arthritis.

6 Apr 2005

International expert group discusses alternatives to COX-2 inhibitors

International group of pain specialists meets to develop recommendations for the treatment of chronic moderate-to-severe pain in the wake of the global withdrawal of rofecoxib (Vioxx) and concerns regarding use of other COX-2 inhibitors.

7 Mar 2005

When breast augmentation or reduction cases are medically necessary

Traditionally, breast augmentation and reduction surgeries are defined by health insurers as cosmetic. It's a definition that often puts patients at odds with health insurers. Payers have difficulty deciding if breast augmentation or reduction cases are medically necessary.

22 Feb 2005

Non Steroidal Anti Inflammatory Drug (NSAIDS) News and Research

Ibruprofen and other commonly used painkillers for treating inflammation may increase the risk of heart attack

Survey highlights need for primary care guidance on NSAID use

Ibuprofen may cause heart attacks - full disclosure of all data - including industry safety data - is essential

Commonly used painkillers for treating inflammation may increase the risk of heart attack

Study suggests continuous NSAID treatment more effectively reduces X-Ray progression than intermittent treatment

Ibuprofen use is associated with an increased risk of breast cancer

Study shows how COX-2 inhibitors lead to heart disease

Use of a common type of antidepressant may increase gastrointestinal (GI) bleeding

Research offers hope for treatment of age-related blindness

Arthritis medications (methotrexate and leflunomide) commonly used in adults are safe and effective in children

NSAIDs okay for tonsillectomy, new study finds

Pfizer separately agrees to suspend sales of Bextra due to FDA evaluation of risks of rare but serious skin reactions

Animi-3 may offer hope for rheumatoid arthritis

Pfizer withdraws Bextra from market

Experts call for improved access to treatment for psoriatic arthritis

International expert group discusses alternatives to COX-2 inhibitors

When breast augmentation or reduction cases are medically necessary

Vioxx could have caused 140000 excess cases of coronary heart disease in the USA since 1999

Warfarin combined with NSAIDs or COX-2 inhibitors increased risk of upper gastrointentinal hemorrhage

Study of patients on COX-2 inhibitors does not show increased cardiovascular risk

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News